PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Statistics

Total Valuation

PMCB has a market cap or net worth of $7.46 million. The enterprise value is -$13.15 million.

Market Cap	7.46M
Enterprise Value	-13.15M

Important Dates

The next estimated earnings date is Friday, March 13, 2026, after market close.

Earnings Date	Mar 13, 2026
Ex-Dividend Date	n/a

Share Statistics

PMCB has 10.74 million shares outstanding. The number of shares has decreased by -15.57% in one year.

Current Share Class	10.74M
Shares Outstanding	10.74M
Shares Change (YoY)	-15.57%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	6.76%
Owned by Institutions (%)	11.18%
Float	9.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.13
P/TBV Ratio	0.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.60

Current Ratio	14.60
Quick Ratio	13.06
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -17.68% and return on invested capital (ROIC) is -6.60%.

Return on Equity (ROE)	-17.68%
Return on Assets (ROA)	-4.76%
Return on Invested Capital (ROIC)	-6.60%
Return on Capital Employed (ROCE)	-7.77%
Weighted Average Cost of Capital (WACC)	6.60%
Revenue Per Employee	n/a
Profits Per Employee	-$3.82M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.51% in the last 52 weeks. The beta is 0.43, so PMCB's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-60.51%
50-Day Moving Average	0.78
200-Day Moving Average	0.92
Relative Strength Index (RSI)	46.24
Average Volume (20 Days)	115,496

Short Selling Information

The latest short interest is 140,630, so 1.31% of the outstanding shares have been sold short.

Short Interest	140,630
Short Previous Month	179,649
Short % of Shares Out	1.31%
Short % of Float	1.41%
Short Ratio (days to cover)	0.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-4.23M
Pretax Income	-7.07M
Net Income	-7.63M
EBITDA	n/a
EBIT	-4.23M
Earnings Per Share (EPS)	-$1.11

Balance Sheet

The company has $20.61 million in cash and n/a in debt, with a net cash position of $20.61 million or $1.92 per share.

Cash & Cash Equivalents	20.61M
Total Debt	n/a
Net Cash	20.61M
Net Cash Per Share	$1.92
Equity (Book Value)	36.55M
Book Value Per Share	5.25
Working Capital	21.44M

Cash Flow

Operating Cash Flow	-4.52M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PMCB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	15.57%
Shareholder Yield	15.57%
Earnings Yield	-102.31%
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 12, 2021. It was a reverse split with a ratio of 1:1,499.93.

Last Split Date	Jul 12, 2021
Split Type	Reverse
Split Ratio	1:1,499.93

Scores

Altman Z-Score	n/a
Piotroski F-Score	2